1st Large real world observational head to head study on tx of Systemic sclerosis - ILD No difference in treatment effe
Tweet Content
1st Large real world observational head to head study on tx of Systemic sclerosis - ILD
No difference in treatment effectiveness of FVC change between tocilizumab, rituximab, mycophenolate and cyclophosphamide!
@RheumNow #ACR23 Abs#2596
#ACRBest https://t.co/GaSnZSCcnZ
Show on Archive Page
On
Display in Search Results
On
PDQ
Off